{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T12:55:48Z","timestamp":1755694548301},"reference-count":50,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2014,8,4]],"date-time":"2014-08-04T00:00:00Z","timestamp":1407110400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0103435","type":"journal-article","created":{"date-parts":[[2014,8,4]],"date-time":"2014-08-04T21:14:01Z","timestamp":1407186841000},"page":"e103435","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":8,"title":["Multi-Agent Chemotherapy Overcomes Glucocorticoid Resistance Conferred by a BIM Deletion Polymorphism in Pediatric Acute Lymphoblastic Leukemia"],"prefix":"10.1371","volume":"9","author":[{"given":"Sheila Xinxuan","family":"Soh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua Yew Suang","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John W. J.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allen Eng Juh","family":"Yeoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. Tiong","family":"Ong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,8,4]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1182\/asheducation.V2012.1.389.3798360","article-title":"The molecular genetic makeup of acute lymphoblastic leukemia","volume":"2012","author":"CG Mullighan","year":"2012","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1056\/NEJMra052603","article-title":"Treatment of acute lymphoblastic leukemia","volume":"354","author":"CH Pui","year":"2006","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1182\/blood-2012-02-265884","article-title":"How I treat relapsed childhood acute lymphoblastic leukemia","volume":"120","author":"F Locatelli","year":"2012","journal-title":"Blood"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1535-6108(02)00032-6","article-title":"Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling","volume":"1","author":"EJ Yeoh","year":"2002","journal-title":"Cancer Cell"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"5202","DOI":"10.1200\/JCO.2008.21.6408","article-title":"IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: a GIMEMA AL WP report","volume":"27","author":"G Martinelli","year":"2009","journal-title":"J Clin Oncol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ccr.2012.06.005","article-title":"Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia","volume":"22","author":"KG Roberts","year":"2012","journal-title":"Cancer Cell"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1126\/science.1234139","article-title":"Cancer pharmacogenomics: early promise, but concerted effort needed","volume":"339","author":"HL McLeod","year":"2013","journal-title":"Science"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1200\/JCO.2009.27.2336","article-title":"Germline genetic variation, cancer outcome, and pharmacogenetics","volume":"28","author":"L Coate","year":"2010","journal-title":"J Clin Oncol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"5145","DOI":"10.1182\/blood-2013-01-480335","article-title":"Germline genetic variations in methotrexate candidate genes are associated with pharmacokinetics, toxicity, and outcome in childhood acute lymphoblastic leukemia","volume":"121","author":"S Radtke","year":"2013","journal-title":"Blood"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1200\/JCO.2011.38.0345","article-title":"ARID5B genetic polymorphisms contribute to racial disparities in the incidence and treatment outcome of childhood acute lymphoblastic leukemia","volume":"30","author":"H Xu","year":"2012","journal-title":"J Clin Oncol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"5972","DOI":"10.1200\/JCO.2008.20.4156","article-title":"Germline genetic variation in an organic anion transporter polypeptide associated with methotrexate pharmacokinetics and clinical effects","volume":"27","author":"LR Trevino","year":"2009","journal-title":"J Clin Oncol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"4752","DOI":"10.1182\/blood-2004-11-4544","article-title":"Pharmacogenetics of outcome in children with acute lymphoblastic leukemia","volume":"105","author":"JC Rocha","year":"2005","journal-title":"Blood"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1038\/ng.2803","article-title":"Inherited GATA3 variants are associated with Ph-like childhood acute lymphoblastic leukemia and risk of relapse","volume":"45","author":"V Perez-Andreu","year":"2013","journal-title":"Nat Genet"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"4197","DOI":"10.1182\/blood-2012-07-440107","article-title":"Genome-wide association study identifies germline polymorphisms associated with relapse of childhood acute lymphoblastic leukemia","volume":"120","author":"JJ Yang","year":"2012","journal-title":"Blood"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1001\/jama.2009.7","article-title":"Genome-wide interrogation of germline genetic variation associated with treatment response in childhood acute lymphoblastic leukemia","volume":"301","author":"JJ Yang","year":"2009","journal-title":"JAMA"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.tibtech.2013.04.004","article-title":"ZFN, TALEN, and CRISPR\/Cas-based methods for genome engineering","volume":"31","author":"T Gaj","year":"2013","journal-title":"Trends Biotechnol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nm.2713","article-title":"A common BIM deletion polymorphism mediates intrinsic resistance and inferior responses to tyrosine kinase inhibitors in cancer","volume":"18","author":"KP Ng","year":"2012","journal-title":"Nat Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1080\/1042819031000097384","article-title":"Deletion of the 5\u2032ABL region in Philadelphia chromosome positive chronic myeloid leukemia: frequency, origin and prognosis","volume":"44","author":"F Morel","year":"2003","journal-title":"Leuk Lymphoma"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"161","DOI":"10.4065\/84.2.161","article-title":"Suboptimal response to or failure of imatinib treatment for chronic myeloid leukemia: what is the optimal strategy?","volume":"84","author":"E Jabbour","year":"2009","journal-title":"Mayo Clin Proc"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"9436","DOI":"10.1158\/0008-5472.CAN-05-0972","article-title":"Low-level expression of proapoptotic Bcl-2-interacting mediator in leukemic cells in patients with chronic myeloid leukemia: role of BCR\/ABL, characterization of underlying signaling pathways, and reexpression by novel pharmacologic compounds","volume":"65","author":"KJ Aichberger","year":"2005","journal-title":"Cancer Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1126\/science.286.5445.1735","article-title":"Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity","volume":"286","author":"P Bouillet","year":"1999","journal-title":"Science"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1371\/journal.pmed.0040316","article-title":"Gefitinib-induced killing of NSCLC cell lines expressing mutant EGFR requires BIM and can be enhanced by BH3 mimetics","volume":"4","author":"MS Cragg","year":"2007","journal-title":"PLoS Med"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"e294","DOI":"10.1371\/journal.pmed.0040294","article-title":"Induction of BIM is essential for apoptosis triggered by EGFR kinase inhibitors in mutant EGFR-dependent lung adenocarcinomas","volume":"4","author":"Y Gong","year":"2007","journal-title":"PLoS Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"6172","DOI":"10.1128\/MCB.24.14.6172-6183.2004","article-title":"Roles of Bim in apoptosis of normal and Bcr-Abl-expressing hematopoietic progenitors","volume":"24","author":"R Kuribara","year":"2004","journal-title":"Mol Cell Biol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"14907","DOI":"10.1073\/pnas.0606176103","article-title":"Bim and Bad mediate imatinib-induced killing of Bcr\/Abl+ leukemic cells, and resistance due to their loss is overcome by a BH3 mimetic","volume":"103","author":"J Kuroda","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"4131","DOI":"10.1182\/blood-2005-04-1595","article-title":"BH3-only proteins Puma and Bim are rate-limiting for gamma-radiation- and glucocorticoid-induced apoptosis of lymphoid cells in vivo","volume":"106","author":"M Erlacher","year":"2005","journal-title":"Blood"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/sj.leu.2405039","article-title":"The BCL2 rheostat in glucocorticoid-induced apoptosis of acute lymphoblastic leukemia","volume":"22","author":"C Ploner","year":"2008","journal-title":"Leukemia"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"23861","DOI":"10.1074\/jbc.M301843200","article-title":"Microarray analysis uncovers the induction of the proapoptotic BH3-only protein Bim in multiple models of glucocorticoid-induced apoptosis","volume":"278","author":"Z Wang","year":"2003","journal-title":"J Biol Chem"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1182\/blood-2005-07-2853","article-title":"Identification of glucocorticoid-response genes in children with acute lymphoblastic leukemia","volume":"107","author":"S Schmidt","year":"2006","journal-title":"Blood"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1182\/blood-2010-05-284968","article-title":"Epigenetic silencing of BIM in glucocorticoid poor-responsive pediatric acute lymphoblastic leukemia, and its reversal by histone deacetylase inhibition","volume":"116","author":"PS Bachmann","year":"2010","journal-title":"Blood"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"55809","DOI":"10.1074\/jbc.M411767200","article-title":"Inhibition of glucocorticoid-induced apoptosis by targeting the major splice variants of BIM mRNA with small interfering RNA and short hairpin RNA","volume":"279","author":"MT Abrams","year":"2004","journal-title":"J Biol Chem"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.exphem.2010.11.009","article-title":"BIM is a prognostic biomarker for early prednisolone response in pediatric acute lymphoblastic leukemia","volume":"39","author":"N Jiang","year":"2011","journal-title":"Exp Hematol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1182\/blood.V92.1.259.413k21_259_266","article-title":"Prednisolone resistance in childhood acute lymphoblastic leukemia: vitro-vivo correlations and cross-resistance to other drugs","volume":"92","author":"GJ Kaspers","year":"1998","journal-title":"Blood"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1200\/JCO.2003.11.031","article-title":"Patient stratification based on prednisolone-vincristine-asparaginase resistance profiles in children with acute lymphoblastic leukemia","volume":"21","author":"ML Den Boer","year":"2003","journal-title":"J Clin Oncol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.3324\/haematol.2011.047613","article-title":"Prediction of outcome by early bone marrow response in childhood acute lymphoblastic leukemia treated in the ALL-BFM 95 trial: differential effects in precursor B-cell and T-cell leukemia","volume":"97","author":"M Lauten","year":"2012","journal-title":"Haematologica"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1182\/blood.V94.4.1209","article-title":"Prednisone response is the strongest predictor of treatment outcome in infant acute lymphoblastic leukemia","volume":"94","author":"M Dordelmann","year":"1999","journal-title":"Blood"},{"key":"ref37","first-page":"2730","article-title":"Philadelphia chromosome-positive (Ph+) childhood acute lymphoblastic leukemia: good initial steroid response allows early prediction of a favorable treatment outcome","volume":"92","author":"M Schrappe","year":"1998","journal-title":"Blood"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1200\/JCO.2011.40.5936","article-title":"Minimal residual disease-guided treatment deintensification for children with acute lymphoblastic leukemia: results from the Malaysia-Singapore acute lymphoblastic leukemia 2003 study","volume":"30","author":"AE Yeoh","year":"2012","journal-title":"J Clin Oncol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/1097-0142(196504)18:4<522::AID-CNCR2820180418>3.0.CO;2-J","article-title":"Continuous Culture of Human Lymphoblasts from Peripheral Blood of a Child with Acute Leukemia","volume":"18","author":"GE Foley","year":"1965","journal-title":"Cancer"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1182\/blood.V65.1.21.21","article-title":"Human acute leukemia cell line with the t(4;11) chromosomal rearrangement exhibits B lineage and monocytic characteristics","volume":"65","author":"RC Stong","year":"1985","journal-title":"Blood"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/ijc.2910530318","article-title":"Phenotypic and molecular analysis of Ph1-chromosome-positive acute lymphoblastic leukemia cell lines","volume":"53","author":"T Miyagi","year":"1993","journal-title":"Int J Cancer"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"e95210","DOI":"10.1371\/journal.pone.0095210","article-title":"Identification of cis-Acting Elements and Splicing Factors Involved in the Regulation of BIM Pre-mRNA Splicing","volume":"9","author":"WC Juan","year":"2014","journal-title":"PLoS One"},{"key":"ref43","unstructured":"DeVita VT Jr, Lawrence TS, Rosenberg SA (2008) DeVita, Hellman, and Rosenberg&apos;s Cancer: Principles &amp; Practice of Oncology. Philadelphia, PA, USA: Wolters Kluwer\/Lippincott Williams &amp; Wilkins. pp 427, 451, 490."},{"key":"ref44","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature09779","article-title":"Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7","volume":"471","author":"IE Wertz","year":"2011","journal-title":"Nature"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ccr.2006.09.006","article-title":"Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistance","volume":"10","author":"G Wei","year":"2006","journal-title":"Cancer Cell"},{"key":"ref46","first-page":"392","article-title":"Cellular drug resistance profiles that might explain the prognostic value of immunophenotype and age in childhood acute lymphoblastic leukemia","volume":"7","author":"R Pieters","year":"1993","journal-title":"Leukemia"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3109\/10428199509112198","article-title":"Clinical and cell biological features related to cellular drug resistance of childhood acute lymphoblastic leukemia cells","volume":"19","author":"GJ Kaspers","year":"1995","journal-title":"Leuk Lymphoma"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"e78582","DOI":"10.1371\/journal.pone.0078582","article-title":"A Single Nucleotide Polymorphism in cBIM Is Associated with a Slower Achievement of Major Molecular Response in Chronic Myeloid Leukaemia Treated with Imatinib","volume":"8","author":"V Augis","year":"2013","journal-title":"PLoS One"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"5240","DOI":"10.1158\/1078-0432.CCR-13-1215","article-title":"Bim polymorphisms: influence on function and response to treatment in children with acute lymphoblastic leukemia","volume":"19(18)","author":"V Gagne","year":"2013","journal-title":"Clin Cancer Res"},{"key":"ref50","article-title":"Impact of promoter polymorphisms in key regulators of the intrinsic apoptosis pathway in childhood acute lymphoblastic leukemia outcome","author":"R Sanchez","year":"2013","journal-title":"Haematologica"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0103435","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,22]],"date-time":"2020-08-22T22:20:42Z","timestamp":1598134842000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0103435"}},"subtitle":[],"editor":[{"given":"Linda","family":"Bendall","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,8,4]]},"references-count":50,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2014,8,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0103435","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,4]]}}}